<html>
<head>PUBMED IDs for KIAA0513</head>
<body bgcolor='#C5F0F2'><h1>KIAA0513</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15511631/'>A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity.</a> October 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17010949/'>Characterization of KIAA0513, a novel signaling molecule that interacts with modulators of neuroplasticity, apoptosis, and the cytoskeleton.</a> October 3  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/26786290/'>Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors.</a> December 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26786262/'>Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer.</a> November 1  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26786229/'>Occult hepatitis B virus infection: influence of S protein variants.</a> October 14  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27391163/'>Comprehensive Analysis of Genome Rearrangements in Eight Human Malignant Tumor Tissues.</a> July 9  2016<br></body></html>
